Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sánchez-Céspedes, J. Articles by Vila, J. Search for Related Content PubMed PubMed Citation Articles by Sánchez-Céspedes, J. Articles by Vila, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2008, p. 2990-2991, Vol. 52, No. 8
0066-4804/08/$08.00+0     doi:10.1128/AAC.00287-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Plasmid-Mediated QnrS2 Determinant from a Clinical Aeromonas veronii Isolate

Top LETTER REFERENCES

 
The main objective of this study was to determine the prevalence of the Qnr determinants in clinical and environmental Aeromonas spp. A total of 52 Aeromonas sp. isolates identified by biochemical methods (5), 25 isolated from natural waters (1) and 27 isolated from clinical samples from hospitals in Valencia, Spain, were tested for quinolone resistance by the disk diffusion method (4) (nalidixic acid, 30 µg; oxolinic acid, 2 µg; flumequine, 30 µg; ciprofloxacin, 5 µg; and levofloxacin, 5 µg). Among the studied isolates, 27 showed resistance to nalidixic acid and susceptibility to ciprofloxacin, 24 isolates were susceptible to both nalidixic acid and ciprofloxacin, and only 1, the A. veronii A272 clinical isolate, was resistant to both nalidixic acid and ciprofloxacin. The isolates resistant to nalidixic acid were also resistant to oxolinic acid and flumequine. Moreover, A. veronii A272 was the only one resistant to levofloxacin. Screening of the qnrA, qnrB, and qnrS genes was performed by multiplex PCR using a set of specific primers for all isolates. Bacterial strains positive for each qnr gene were used as positive controls (Klebsiella pneumoniae UAB1 for qnrA, Escherichia coli J53 pMG252 for qnrB, and E. coli J53 pMG298 for qnrS) and were run in each batch of tested samples. Only an A. veronii clinical isolate (A. veronii A272) presented a qnr gene, which showed 100% homology with the qnrS2 gene previously reported in an isolate from the bacterial community of a wastewater treatment plant in Germany (2) and in a non-Typhi Salmonella clinical isolate in the United States (6).

The qnrS2-carrying strain was identified as A. veronii by sequencing of the 16S rRNA gene (10). The MICs for nalidixic acid, ciprofloxacin, and norfloxacin were determined using the Etest method (AB Biodisk, Solna, Sweden). CLSI breakpoints were used to define susceptibility (4). The MICs showed by this strain were >256 mg/liter, 8 mg/liter, and 12 mg/liter to nalidixic acid, ciprofloxacin, and norfloxacin, respectively (Table 1). PCR amplification of the quinolone resistance-determining regions of the gyrA and parC genes was performed with primers previously described (7). A. veronii CECT 4260 and CECT 4258 strains, susceptible to quinolones, were included. The nucleotide and deduced protein sequences were analyzed with software available on the Internet at the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov). Comparison of the deduced amino acid sequences of GyrA and ParC with those of susceptible A. veronii CECT 4258 and CECT 4260 strains showed that A. veronii A272 carried mutations in the quinolone resistance-determining regions of both the gyrA and parC genes (Table 1). As previously reported, the same mutations were found in a strain that showed a MIC to ciprofloxacin of 0.5 mg/liter (7). Therefore, the level of resistance to these antibacterial agents could be explained by these two mutations in the gyrA and parC genes plus the additive effect of the presence of the QnrS2 determinant as previously suggested by Martinez-Martinez et al. (9).

View this table: [in this window] [in a new window]

TABLE 1. Quinolone susceptibilities of the A. veronii A272 clinical isolate, the E. coli J53 isolate, and the E. coli J53 isolate transformed with plasmid pA272

Conjugation experiments were performed by the liquid mating-out assay using rifampin-resistant E. coli J53 and an environmental Aeromonas subsp. resistant to rifampin as recipient strains and nalidixic acid as the selective agent. The conjugation experiments provided negative results. After the extraction and purification of the qnrS2-containing plasmid (pA272) (the qnrS2-containing plasmid showed a size ranging from 48.5 to 97.0 kb [Lambda ladder PFG marker; New England Biolabs, Ipswich, MA]), a transformation experiment was done with rifampin-resistant E. coli J53 by electroporation. The quinolone MICs of the recipient E. coli J53 strain and of the transformed strain, determined by Etest, revealed a 10- to more than 64-fold increase in the transformant (Table 1). In addition, we did not observe increased resistance to β-lactam antibiotics, aminoglycosides, chloramphenicol, and tetracycline in the transformed E. coli strain (data not shown).

To analyze the genetic context of the qnrS2 gene, the DNA of A. veronii A272 was digested with MspI "C*CGG" (recognition site) (New England Biolabs, Ipswich, MA), which does not have recognition sites in the qnrS2 gene. The fragments obtained were autoligated overnight at 16°C using T4 DNA ligase (Promega Biotech Ibérica, Madrid, Spain) and used as a template for a PCR with inverse primers designed from the qnrS2 gene sequence (qnrs2invF, 5'-GAACAGCTTCTCGAAGCGTTG-3', and qnrs2invR, 5'-ACTGTGGTGTCGATATGTGTG-3'). The resulting bands were sequenced using the BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems, Warrington, United Kingdom). The sequence obtained around the qnrS2 gene (approximately 300 bp from each side) showed that this gene was inserted into an mpR gene as previously reported by Cattoir et al. (3).

This is the first time that a qnrS-containing plasmid in an Aeromonas sp. clinical isolate has been described. Up to now, qnr determinants have only been reported in Enterobacteriaceae (8, 11-15), except for a recent report on a qnrS-containing plasmid found in environmental A. caviae (A. punctata) and A. media isolates (3). The identification of a qnrS2 gene in a clinical isolate not within the Enterobacteriaceae family emphasizes the versatility of these determinants to spread among the different bacterial species with the consequent potential risk for human health.

 
This work has been supported in part by grants FIS 05/0068 from the Ministry of Health, Spain; CGL2004-02009 from the Ministry of Education and Science, Spain; and SGR00444 from the Department d'Universitats, Recerca I Societat de la Informació de la Generalitat de Catalunya, Spain (to J.V.). M.D.B. is the recipient of a Ph.D. fellowship from the Spanish government (Ministry of Education and Science).

We thank G. Jacoby for providing us with the control strains used in this study.

 
Published ahead of print on 27 May 2008.

J. Sanchez-Cespedes and M. D. Blasco contributed equally to the experimental work.

Top LETTER REFERENCES

 

1
1. Blasco, M. D., C. Esteve, and E. Alcaide. 20 February 2008, posting date. Multiresistant waterborne pathogens isolated from water reservoirs and cooling systems. J. Appl. Microbiol. doi:10.1111/j.1365-2672.2008.03765.x.
2
2. Bonemann, G., M. Stiens, A. Puhler, and A. Schluter. 2006. Mobilizable IncQ-related plasmid carrying a new quinolone resistance gene, qnrS2, isolated from the bacterial community of a wastewater treatment plant. Antimicrob. Agents Chemother. 50:3075-3080.[Abstract/Free Full Text]
3
3. Cattoir, V., L. Poirel, C. Aubert, C. Soussy, and P. Nordmann. 2008. Unexpected occurrence of plasmid-mediated quinolone resistance determinants in environmental Aeromonas spp. Emerg. Infect. Dis. 14:231-237.[Medline]
4
4. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
5
5. Esteve, C. 1995. Numerical taxonomy of Aeromonadaceae and Vibrionaceae isolated from fish and surrounding aquatic environment. Syst. Appl. Microbiol. 18:391-402.
6
6. Gay, K., A. Robicsek, J. Strahilevitz, C. H. Park, G. Jacoby, T. J. Barrett, F. Medalla, T. M. Chiller, and D. C. Hooper. 2006. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin. Infect. Dis. 43:297-304.[CrossRef][Medline]
7
7. Goni-Urriza, M., C. Arpin, M. Capdepuy, V. Dubois, P. Caumette, and C. Quentin. 2002. Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance. Antimicrob. Agents Chemother. 46:350-359.[Abstract/Free Full Text]
8
8. Lavilla, S., J. J. Gonzalez-Lopez, M. Sabate, A. Garcia-Fernandez, M. N. Larrosa, R. M. Bartolome, A. Carattoli, and G. Prats. 2008. Prevalence of qnr genes among extended-spectrum β-lactamase-producing enterobacterial isolates in Barcelona, Spain. J. Antimicrob. Chemother. 61:291-295.[Abstract/Free Full Text]
9
9. Martinez-Martinez, L., A. Pascual, I. Garcia, J. Tran, and G. A. Jacoby. 2003. Interaction of plasmid and host quinolone resistance. J. Antimicrob. Chemother. 51:1037-1039.[Free Full Text]
10
10. Martinez-Murcia, A. J., S. Benlloch, and M. D. Collins. 1992. Phylogenetic interrelationships of members of the genera Aeromonas and Plesiomonas as determined by 16S ribosomal DNA sequencing: lack of congruence with results of DNA-DNA hybridizations. Int. J. Syst. Bacteriol. 42:412-421.[Abstract/Free Full Text]
11
11. Park, Y. J., J. K. Yu, S. Lee, E. J. Oh, and G. J. Woo. 2007. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea. J. Antimicrob. Chemother. 60:868-871.[Abstract/Free Full Text]
12
12. Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.[CrossRef][Medline]
13
13. Strahilevitz, J., D. Engelstein, A. Adler, V. Temper, A. E. Moses, C. Block, and A. Robicsek. 2007. Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. Antimicrob. Agents Chemother. 51:3001-3003.[Abstract/Free Full Text]
14
14. Wang, M., D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2004. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob. Agents Chemother. 48:1295-1299.[Abstract/Free Full Text]
15
15. Wu, J. J., W. C. Ko, S. H. Tsai, and J. J. Yan. 2007. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob. Agents Chemother. 51:1223-1227.[Abstract/Free Full Text]

						Javier Sánchez-Céspedes Servei de Microbiologia, Centre de Diagnòstic Biomèdic Hospital Clínic, IDIBAPS, Facultat de Medicina Universitat de Barcelona 08036 Barcelona, Spain M. Dolores Blasco Departament de Microbiologia i Ecologia Universitat de València Valencia, Spain Sara Marti Verónica Alba Servei de Microbiologia, Centre de Diagnòstic Biomèdic Hospital Clínic, IDIBAPS, Facultat de Medicina Universitat de Barcelona 08036 Barcelona, Spain Elena Alcalde Consuelo Esteve Departament de Microbiologia i Ecologia Universitat de València Valencia, Spain Jordi Vila* Servei de Microbiologia, Centre de Diagnòstic Biomèdic Hospital Clínic, IDIBAPS, Facultat de Medicina Universitat de Barcelona 08036 Barcelona, Spain
						* Phone: 34-93-2275522, Fax: 34-93-2279372, E-mail: jvila{at}ub.edu

---

Antimicrobial Agents and Chemotherapy, August 2008, p. 2990-2991, Vol. 52, No. 8
0066-4804/08/$08.00+0     doi:10.1128/AAC.00287-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Mendez Arancibia, E., Pitart, C., Ruiz, J., Marco, F., Gascon, J., Vila, J. (2009). Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea. J Antimicrob Chemother 64: 343-347 [Abstract] [Full Text]  
• Kim, H. B., Park, C. H., Kim, C. J., Kim, E.-C., Jacoby, G. A., Hooper, D. C. (2009). Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period. Antimicrob. Agents Chemother. 53: 639-645 [Abstract] [Full Text]  
• Picao, R. C., Poirel, L., Demarta, A., Silva, C. S. F., Corvaglia, A. R., Petrini, O., Nordmann, P. (2008). Plasmid-mediated quinolone resistance in Aeromonas allosaccharophila recovered from a Swiss lake. J Antimicrob Chemother 62: 948-950 [Abstract] [Full Text]  

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sánchez-Céspedes, J. Articles by Vila, J. Search for Related Content PubMed PubMed Citation Articles by Sánchez-Céspedes, J. Articles by Vila, J.